85-1824-41 Caveolin 1 (CAV1) Recombinant, Human 50ug 153943
特徴
- Recombinant protein corresponding to aa2-104 with an N-terminal His-Tag from human CAV1expressed in E. coli (Q03135)
- Amino Acid Sequence:MGHHHHHHSG SEF- SGGKYVDSE GHLYTVPIRE QGNIYKPNNK AMADELSEKQ VYDAHTKEID LVNRDPKHLN DDVVKIDFED VIAEPEGTHS FDGIWKASFT TFTVTKYWFY RLLS
- Predicted Molecular Weight:13.4kD
- Predicted Isoelectric Point:5.7
- Subcellular Location:Golgi, apparatus membrane; Peripheral membrane protein; Cell membrane; Membrane, caveola; Membrane raft
- Accurate Molecular Mass:16kD as determined by SDS-PAGE reducing conditionsNote: The possible reasons that the actual band size differs from the predicted are as follows:1. Splice variants: Alternative splicing may create different sized proteins from the same gene2. Relative charge: The composition of amino acids may affect the charge of the protein
- 3. Post-translational modification: Phosphorylation, glycosylation, methylation etc
- 4. Post-translation cleavage: Many proteins are synthesized as pro-proteins and then cleaved to give the active form
- 5. Polymerization of the target protein: Dimerization, multimerization etc.
- Applications:Suitable for use in ELISA, Western Blot, Immunoprecipitation and SDS-PAGE
- Other applications not tested.
- Recommended Dilutions:Optimal dilutions to be determined by the researcher.
- Included Protein Molecular Weight Marker:168631: Unstained Protein Molecular Weight Marker, 10-70kD. No heating, diluting or reducing agents needed
- MW: 10kD, 14kD, 18kD, 22kD, 26kD, 33kD, 44kD, 70kD Double intensity: 10kD, 18kD, 26kDSupplied in 62.5mM Tris-H3PO4, pH 7.5, 1mM EDTA, 2% SDS, 100mM DTT, 1mM sodium azide, 0.01% bromo-phenol blue, 33% glycerol. Add 3-5ul/well for mini gels; 7ul/well for large gels. Store at -20°C Stable for 6 months after receipt.
- Storage and Stability:Lyophilized powder may be stored at -70°C. Stable for 6 months after receipt. Reconstitute with sterile ddH2O. Aliquot to avoid repeated freezing and thawing. Store at -70°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.
- Note:Thermal stability is described by the loss rate of the target protein. The loss rate was determined by accelerated thermal degradation by incubating the protein at 37°C for 48h, with no obvious degradation or precipitation observed. Protein loss is <5% within the expiration date under appropriate storage conditions.
仕様
- Size:50ug
- Source Antigen:Recombinant, E. coli
- Grade:Highly Purified
- Purity:≥95%. Endotoxin: ≤1EU/ug (LAL)
- Form:Supplied as lyophilized powder from 20mM Tris, 150mM sodium chloride, pH 8.0, 1mM EDTA, 1mM DTT, 0.01% sarcosyl, 5% trehalose, 0.02% sodium azide. Reconstitute with sterile ddH2O.
- Molecular Weight Non Ab:13.4
- Swiss Prot Number:Q03135
- EU Commodity Code:30021019
- この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
- 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
- 【試薬に関するお問合せ】
- アズワン株式会社 試薬・プロセス材料グループ
- TEL:06-6447-8641
- FAX:06-6447-8642
- E-mail:[email protected]
商品のバリエーション (サイズ違い・スペック違い・オプション品など)
| 商品イメージ | アズワン品番 商品名 |
|---|---|
|
85-1824-40
Caveolin 1 (CAV1) Recombinant, Human 10ug
|
|
|
85-1824-41
Caveolin 1 (CAV1) Recombinant, Human 50ug
|
|
|
85-1824-42
Caveolin 1 (CAV1) Recombinant, Human 200ug
|
よくあるご質問(FAQ)
掲載カタログ情報
| 掲載カタログ名 | 掲載ページ |
|---|





